Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Ordinary Share $0.00001 par value
-
Shares outstanding
-
50,588,235
-
Total 13F shares
-
21,271,423
-
Share change
-
+937,319
-
Total reported value
-
$490,440,514
-
Put/Call ratio
-
1.9%
-
Price per share
-
$23.05
-
Number of holders
-
86
-
Value change
-
+$17,057,826
-
Number of buys
-
37
-
Number of sells
-
48
Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH) as of Q3 2014
As of 30 Sep 2014,
Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,271,423 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, IRIDIAN ASSET MANAGEMENT LLC/CT, FIRST MANHATTAN CO, State Street Corp, OPPENHEIMER FUNDS INC, Foundation Asset Management, LP, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., and D. E. Shaw & Co., Inc..
This page lists
86
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.